Provectus Biopharmaceuticals (PVCT) Intangibles (2010 - 2020)
Provectus Biopharmaceuticals' Intangibles came in at $60,327 for Q1 2020, down 91.8% from $731,447 a year earlier and down 73.6% from the prior quarter.
Provectus Biopharmaceuticals (PVCT) Intangibles (2010 - 2020) Analysis & Trends
At the end of FY2019, Provectus Biopharmaceuticals' Intangibles was $228,107, down 74.6% from FY2018.
- Intangibles has declined in each of the last nine years, with a five-year compound annual growth rate of -42.4% (FY2014 to FY2019).
- Going back by year, Intangibles was $899,227 in FY2018 (-42.7%), $1.57 million in FY2017 (-29.9%), $2.24 million in FY2016 (-23.0%) and $2.91 million in FY2015 (-18.7%).
- The Q1 2020 figure represents the lowest quarterly Intangibles in data going back to Q4 2010.
- Year-over-year, Intangibles has declined for 32 consecutive quarters, with an average decline of 56.0% over the last eight quarters.
- The year-over-year decline in Intangibles has ranged between 17.1% (Q2 2015) and 91.8% (Q1 2020) over the last five years.
- Business Quant data shows PVCT's Intangibles at $228,107 (Q4 2019), $395,887 (Q3 2019) and $563,667 (Q2 2019) in the three quarters before Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 60,327.00 |
| Dec 31, 2019 | 228,107.00 |
| Sep 30, 2019 | 395,887.00 |
| Jun 30, 2019 | 563,667.00 |
| Mar 31, 2019 | 731,447.00 |
| Dec 31, 2018 | 899,227.00 |
| Sep 30, 2018 | 1.07 Mn |
| Jun 30, 2018 | 1.23 Mn |
| Mar 31, 2018 | 1.40 Mn |
| Dec 31, 2017 | 1.57 Mn |
| Sep 30, 2017 | 1.74 Mn |
| Jun 30, 2017 | 1.91 Mn |
| Mar 31, 2017 | 2.07 Mn |
| Dec 31, 2016 | 2.24 Mn |
| Sep 30, 2016 | 2.41 Mn |
| Jun 30, 2016 | 2.58 Mn |
| Mar 31, 2016 | 2.74 Mn |
| Dec 31, 2015 | 2.91 Mn |
| Sep 30, 2015 | 3.08 Mn |
| Jun 30, 2015 | 3.25 Mn |
Provectus Biopharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=PVCT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();